Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis
- 31 December 2011
- journal article
- review article
- Published by Elsevier BV in Journal of Cystic Fibrosis
- Vol. 10 (6), 387-400
- https://doi.org/10.1016/j.jcf.2011.06.014
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Application of quantitative PCR to the diagnosis and monitoring of Pseudomonas aeruginosa colonization in 5–18-year-old cystic fibrosis patientsJournal of Medical Microbiology, 2011
- Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosisThe ISME Journal, 2010
- Pulmonary exacerbations in cystic fibrosis with negative bacterial culturesPediatric Pulmonology, 2010
- Measuring and improving respiratory outcomes in cystic fibrosis lung disease: Opportunities and challenges to therapyJournal of Cystic Fibrosis, 2010
- In Vitro Pharmacodynamics of Levofloxacin and Other Aerosolized Antibiotics under Multiple Conditions Relevant to Chronic Pulmonary Infection in Cystic FibrosisAntimicrobial Agents and Chemotherapy, 2010
- Comparison of Methods To Test Antibiotic Combinations against Heterogeneous Populations of Multiresistant Pseudomonas aeruginosa from Patients with Acute Infective Exacerbations in Cystic FibrosisAntimicrobial Agents and Chemotherapy, 2009
- A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patientsProceedings of the National Academy of Sciences of the United States of America, 2008
- Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infectionsNature Reviews Microbiology, 2006
- Aminoglycoside antibiotics induce bacterial biofilm formationNature, 2005
- Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosisPediatric Pulmonology, 2002